$ Value
$77K
Shares
15,000
Price
$5
Filed
Nov 19
Insider
Name
Liu Dongfang
Title
CHIEF MEDICAL OFFICER
CIK
0001937915
Roles
Transaction Details
Transaction Date
2025-11-19
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
18,000
Footnotes
Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.21. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. | Includes 3,000 shares acquired on November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. | Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Filing Info
Liu Dongfang's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | NUVB | M | $97K |
| 2026-04-17 | NUVB | ▼ | $251K |
| 2026-04-17 | NUVB | M | $0 |
| 2026-02-27 | NUVB | A | $0 |
| 2025-12-01 | NUVB | M | $440K |
| 2025-12-01 | NUVB | ▼ | $1.2M |
| 2025-12-01 | NUVB | M | $0 |
| 2025-11-26 | NUVB | M | $36K |
| 2025-11-26 | NUVB | ▼ | $80K |
| 2025-11-26 | NUVB | M | $0 |
Other Insiders at NUVB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hung David
PRESIDENT AND CEO
|
— | — | 2026-02-27 |
|
Wentworth Kerry
CHIEF REGULATORY OFFICER
|
— | $1.1M | 2026-04-17 |
| Cui Xiangmin | — | — | 2026-02-27 |
|
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-27 |
|
Markel Stacy
CHIEF PEOPLE OFFICER
|
— | — | 2026-02-27 |
|
Hanley David C.
CHIEF TECHNICAL OPERATIONS
|
— | — | 2026-02-27 |
|
Liu Dongfang
CHIEF MEDICAL OFFICER
|
— | $251K | 2026-04-17 |
|
Makunje Moses
SEE REMARKS
|
— | — | 2026-02-27 |
|
Sjogren Colleen
Chief Commercial Officer
|
— | — | 2026-02-27 |
|
Sauvage Philippe
Chief Financial Officer
|
— | — | 2026-02-27 |